These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36186902)

  • 1. Hexokinase 2 Is a Pivot for Lovastatin-induced Glycolysis-to-Autophagy Reprogramming in Triple-Negative Breast Cancer Cells.
    Xue L; Wu M; Li Y; Chen S; Wu M; Zhu J; Ding S; Zhang Q; Zheng C; He G; Fu S; Li G; Deng X
    J Cancer; 2022; 13(12):3368-3377. PubMed ID: 36186902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lovastatin Inhibits EMT and Metastasis of Triple-Negative Breast Cancer Stem Cells Through Dysregulation of Cytoskeleton-Associated Proteins.
    Zheng C; Yan S; Lu L; Yao H; He G; Chen S; Li Y; Peng X; Cheng Z; Wu M; Zhang Q; Li G; Fu S; Deng X
    Front Oncol; 2021; 11():656687. PubMed ID: 34150623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of lovastatin- and docosahexaenoic acid-initiated autophagy in triple negative breast cancer reverted resistance and enhanced cytotoxicity.
    El-Ashmawy NE; Al-Ashmawy GM; Amr EA; Khedr EG
    Life Sci; 2020 Oct; 259():118212. PubMed ID: 32768581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymoquinone Inhibits Proliferation and Migration of MDA-MB-231 Triple Negative Breast Cancer Cells by Suppressing Autophagy, Beclin-1 and LC3.
    Ünal TD; Hamurcu Z; Delibaşı N; Çınar V; Güler A; Gökçe S; Nurdinov N; Ozpolat B
    Anticancer Agents Med Chem; 2021; 21(3):355-364. PubMed ID: 32767958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulated Ribosome Biogenesis Is a Targetable Vulnerability in Triple-Negative Breast Cancer: MRPS27 as a Key Mediator of the Stemness-inhibitory Effect of Lovastatin.
    Zheng C; Yao H; Lu L; Li H; Zhou L; He X; Xu X; Xia H; Ding S; Yang Y; Wang X; Wu M; Xue L; Chen S; Peng X; Cheng Z; Wang Y; He G; Fu S; Keller ET; Liu S; Jiang YZ; Deng X
    Int J Biol Sci; 2024; 20(6):2130-2148. PubMed ID: 38617541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cantharidin Inhibits the Growth of Triple-Negative Breast Cancer Cells by Suppressing Autophagy and Inducing Apoptosis in Vitro and in Vivo.
    Li HC; Xia ZH; Chen YF; Yang F; Feng W; Cai H; Mei Y; Jiang YM; Xu K; Feng DX
    Cell Physiol Biochem; 2017; 43(5):1829-1840. PubMed ID: 29050003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of 3PO analog PFK15 and siPFKL efficiently suppresses the migration, colony formation ability, and PFK-1 activity of triple-negative breast cancers by reducing the glycolysis.
    Kashyap A; Umar SM; Dev J R A; Mathur SR; Gogia A; Batra A; Deo SVS; Prasad CP
    J Cell Biochem; 2023 Sep; 124(9):1259-1272. PubMed ID: 37450687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethanol Extract of
    Chen X; Li S; Li D; Li M; Su Z; Lai X; Zhou C; Chen S; Li S; Yang X; Su J; Zhang Y
    Front Pharmacol; 2020; 11():606. PubMed ID: 32411003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic Response of Triple-Negative Breast Cancer to Folate Restriction.
    Coleman MF; O'Flanagan CH; Pfeil AJ; Chen X; Pearce JB; Sumner S; Krupenko SA; Hursting SD
    Nutrients; 2021 May; 13(5):. PubMed ID: 34068120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting LC3 and Beclin-1 autophagy genes suppresses proliferation, survival, migration and invasion by inhibition of Cyclin-D1 and uPAR/Integrin β1/ Src signaling in triple negative breast cancer cells.
    Hamurcu Z; Delibaşı N; Geçene S; Şener EF; Dönmez-Altuntaş H; Özkul Y; Canatan H; Ozpolat B
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):415-430. PubMed ID: 29288363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockout of VDAC1 in H9c2 Cells Promotes Oxidative Stress-Induced Cell Apoptosis through Decreased Mitochondrial Hexokinase II Binding and Enhanced Glycolytic Stress.
    Yang M; Sun J; Stowe DF; Tajkhorshid E; Kwok WM; Camara AKS
    Cell Physiol Biochem; 2020 Sep; 54(5):853-874. PubMed ID: 32901466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different mechanisms involved in the berberine-induced antiproliferation effects in triple-negative breast cancer cell lines.
    Lin YS; Chiu YC; Tsai YH; Tsai YF; Wang JY; Tseng LM; Chiu JH
    J Cell Biochem; 2019 Aug; 120(8):13531-13544. PubMed ID: 30957305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerasomal Lovastatin Nanohybrids for Efficient Inhibition of Triple-Negative Breast Cancer Stem Cells To Improve Therapeutic Efficacy.
    Song L; Tao X; Lin L; Chen C; Yao H; He G; Zou G; Cao Z; Yan S; Lu L; Yi H; Wu D; Tan S; Ouyang W; Dai Z; Deng X
    ACS Appl Mater Interfaces; 2018 Feb; 10(8):7022-7030. PubMed ID: 29405062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel orally available seleno-purine molecule suppresses triple-negative breast cancer cell proliferation and progression to metastasis by inducing cytostatic autophagy.
    Chang CH; Bijian K; Wernic D; Su J; da Silva SD; Yu H; Qiu D; Asslan M; Alaoui-Jamali MA
    Autophagy; 2019 Aug; 15(8):1376-1390. PubMed ID: 30773992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CircWHSC1 regulates malignancy and glycolysis by the miR-212-5p/AKT3 pathway in triple-negative breast cancer.
    Ding L; Xie Z
    Exp Mol Pathol; 2021 Dec; 123():104704. PubMed ID: 34624276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platinum complexes inhibit HER-2 enriched and triple-negative breast cancer cells metabolism to suppress growth, stemness and migration by targeting PKM/LDHA and CCND1/BCL2/ATG3 signaling pathways.
    Bai X; Ali A; Lv Z; Wang N; Zhao X; Hao H; Zhang Y; Rahman FU
    Eur J Med Chem; 2021 Nov; 224():113689. PubMed ID: 34293698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of a Glycolytic Signature and Its Regulation by Y-Box-Binding Protein 1 in Triple-Negative Breast Cancer.
    Lai YW; Hsu WJ; Lee WY; Chen CH; Tsai YH; Dai JZ; Yang CC; Lin CW
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diclofenac impairs the proliferation and glucose metabolism of triple-negative breast cancer cells by targeting the c-Myc pathway.
    Yang L; Li J; Li Y; Zhou Y; Wang Z; Zhang D; Liu J; Zhang X
    Exp Ther Med; 2021 Jun; 21(6):584. PubMed ID: 33850556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA HANR modulates the glucose metabolism of triple negative breast cancer via stabilizing hexokinase 2.
    Han G; Bai X; Li F; Huang L; Hao Y; Li W; Bu P; Zhang H; Liu X; Xie J
    Heliyon; 2024 Jan; 10(1):e23827. PubMed ID: 38192790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of the novel histone deacetylase inhibitor YCW1 and radiation induces autophagic cell death through the downregulation of BNIP3 in triple-negative breast cancer cells in vitro and in an orthotopic mouse model.
    Chiu HW; Yeh YL; Wang YC; Huang WJ; Ho SY; Lin P; Wang YJ
    Mol Cancer; 2016 Jun; 15(1):46. PubMed ID: 27286975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.